Loading organizations...
Life Technologies developed and supplied biotechnology products and services for life sciences research, diagnostics, and applied markets. The company offered a comprehensive suite of tools, including advanced systems like the Ion Proton Sequencer, along with essential consumables and specialized services. Its technical approach focused on integrated solutions, empowering scientists with critical technologies for genomics, proteomics, and cell biology applications.
Life Technologies was established in November 2008, born from the merger of Invitrogen Corporation and Applied Biosystems Inc. This strategic consolidation united two major biotechnology players, aiming to create a more robust platform for innovation. The independent corporation was formed to accelerate the development and global delivery of essential research tools.
The company served a diverse clientele, including academic, government, and pharmaceutical researchers, alongside clinical diagnostic laboratories. Life Technologies pursued a vision of advancing scientific discovery by equipping professionals with innovative tools for understanding biological systems. Its mission aimed to facilitate breakthroughs that contribute to improving the human condition.
Life has 1 tracked investment across 1 company. The latest tracked deal is $1.0M Seed in Spintly in November 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Nov 1, 2022 | Spintly | $1.0M Seed | — | Accel, Riso Capital, Dheeraj Pandey, 91 Ventures, Accel Nest, Defang Technology, Kyto Technology & Life Science, Vikrant Varshney |